Skip to content
Financing

Stock Issuance Proceeds

Guardant Health Stock Issuance Proceeds decreased by 98.9% to $3.65M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 375.4%, from $768K to $3.65M.

Analysis

StatementCash Flow Statement
SectionFinancing
CategoryLiquidity
SignalContext dependent
VolatilityVolatile
First reportedQ1 2016
Last reportedQ1 2026May 7, 2026

How to read this metric

High proceeds indicate capital raising activities to fund operations, while low proceeds suggest sufficient internal cash generation or limited equity market activity.

Detailed definition

This represents the cash inflows received from the issuance of common stock, including proceeds from public offerings or...

Peer comparison

Frequent in growth-stage companies requiring external funding to reach profitability.

Metric ID: proceeds_from_stock_issuance

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value-$4.46M$0$0$963K-$963K$0$0$157K$381.4M-$472.16M$90.6M$213K-$213K$0$0$768K$1.56M$3.72M$327.3M$3.65M
QoQ Change+100.0%-200.0%+100.0%>999%-223.8%+119.2%-99.8%-200.0%+100.0%+102.7%+139.0%>999%-98.9%
YoY Change+78.4%-83.7%>999%+35.7%-100.1%+100.0%-100.0%+260.6%+831.0%+375.4%
Range-$472.16M$381.4M
CAGR-4.1%
Avg YoY Growth>999%
Median YoY Growth+89.2%

Frequently Asked Questions

What is Guardant Health's stock issuance proceeds?
Guardant Health (GH) reported stock issuance proceeds of $3.65M in Q1 2026.
How has Guardant Health's stock issuance proceeds changed year-over-year?
Guardant Health's stock issuance proceeds increased by 375.4% year-over-year, from $768K to $3.65M.
What does stock issuance proceeds mean?
Cash received from selling shares of the company's stock.